Inventor · disambiguated record
Shaun Cordoba
Also filed as: CORDOBA SHAUN
39 granted patents·51 pending applications·133 citations·filing 2014–2025
97Inventor score
Top patents by PatentIndex Score
90 records- 0196US11034750B2Chimeric antigen receptor (CAR) comprising a CD19-binding domainAUTOLUS LTD·Filed 2018·Granted Jun 15, 2021·8 cites·7 claims
- 0296US10172885B2CellUCL BUSINESS PLC·Filed 2014·Granted Jan 8, 2019·24 cites·17 claims
- 0395US12187769B2CellAUTOLUS LTD·Filed 2023·Granted Jan 7, 2025·2 cites·5 claims
- 0495US11091532B2T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptorAUTOLUS LTD·Filed 2015·Granted Aug 17, 2021·8 cites·16 claims
- 0594US11590170B2Chimeric antigen receptorAUTOLUS LTD·Filed 2022·Granted Feb 28, 2023·3 cites·6 claims
- 0694US11434293B2Anti TRBC1 antigen binding domainsAUTOLUS LTD·Filed 2021·Granted Sep 6, 2022·7 cites·10 claims
- 0793US10981970B2Chimeric antigen receptor (CAR) comprising a CD22-binding domainAUTOLUS LTD·Filed 2018·Granted Apr 20, 2021·4 cites·8 claims
- 0893US10800854B2Chimeric cytokine receptors and encoding nucleic acidsAUTOLUS LTD·Filed 2016·Granted Oct 13, 2020·6 cites·22 claims
- 0993US10172886B2CellUCL BUSINESS PLC·Filed 2014·Granted Jan 8, 2019·16 cites·16 claims
- 1093US10098926B2CellUCL BUSINESS PLC·Filed 2017·Granted Oct 16, 2018·10 cites·4 claims
- 1192US11440961B2Anti TRBC1 antigen binding domainsAUTOLUS LTD·Filed 2018·Granted Sep 13, 2022·7 cites·11 claims
- 1292US10800855B2Chimeric cytokine receptors and encoding nucleic acidsAUTOLUS LTD·Filed 2018·Granted Oct 13, 2020·4 cites·15 claims
- 1390US11058722B2Chimeric antigen receptor comprising a cartilage-oligomeric matrix protein (comp) coiled-coil spacer domainAUTOLUS LTD·Filed 2016·Granted Jul 13, 2021·4 cites·13 claims
- 1490US10174099B2CellUCL BUSINESS PLC·Filed 2017·Granted Jan 8, 2019·5 cites·3 claims
- 1589US11851672B2CAR T-cells comprising transcriptional circuitsAUTOLUS LTD·Filed 2018·Granted Dec 26, 2023·3 cites·2 claims
- 1689US11365262B2CellAUTOLUS LTD·Filed 2016·Granted Jun 21, 2022·4 cites·19 claims
- 1789US2025353893A1CellAUTOLUS LTD·Filed 2025·Application pending·0 cites
- 1887US12049510B2Chimeric antigen receptorAUTOLUS LTD·Filed 2019·Granted Jul 30, 2024·2 cites·14 claims
- 1987US11180553B2Chimeric antigen receptorAUTOLUS LTD·Filed 2017·Granted Nov 23, 2021·4 cites·12 claims
- 2087US10654927B2Signalling systemUCL BUSINESS PLC·Filed 2015·Granted May 19, 2020·4 cites·16 claims
- 2186US12398194B2Cell lexpressing two chimeric antigen receptors (CARs) at the cell surfaceAUTOLUS LTD·Filed 2023·Granted Aug 26, 2025·0 cites·20 claims
- 2286US11479613B2Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteinsAUTOLUS LTD·Filed 2020·Granted Oct 25, 2022·1 cites·11 claims
- 2386US2024033292A1CellAUTOLUS LTD·Filed 2023·Application pending·0 cites
- 2484US2024033289A1CellAUTOLUS LTD·Filed 2023·Application pending·0 cites
- 2583US12234295B2Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereofAUTOLUS LTD·Filed 2022·Granted Feb 25, 2025·0 cites·22 claims
- 2683US11701386B2CellAUTOLUS LTD·Filed 2018·Granted Jul 18, 2023·1 cites·7 claims
- 2782US11959084B2Nucleic acid constructAUTOLUS LTD·Filed 2019·Granted Apr 16, 2024·1 cites·21 claims
- 2881US2025197464A1CellAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 2980US2025277047A1Chimeric antigen receptorAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 3079US11466070B2Signalling systemAUTOLUS LTD·Filed 2017·Granted Oct 11, 2022·2 cites·12 claims
- 3178US12454578B2Cytolytic immune cell comprising BCMA- and CD19-specific chimeric antigen receptorsAUTOLUS LTD·Filed 2022·Granted Oct 28, 2025·0 cites·4 claims
- 3278US11345734B2Chimeric T cellAUTOLUS LTD·Filed 2016·Granted May 31, 2022·1 cites·5 claims
- 3378US11242377B2Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomainsAUTOLUS LTD·Filed 2016·Granted Feb 8, 2022·1 cites·35 claims
- 3478US2025019434A1Chimeric antigen receptorAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 3578US2024384278A1Nucleic acid constructAUTOLUS LTD·Filed 2024·Application pending·0 cites
- 3677US2025333538A1Chimeric cytokine receptorAUTOLUS LTD·Filed 2025·Application pending·0 cites
- 3774US12492410B2Engineered cytolytic immunecellAUTOLUS LTD·Filed 2022·Granted Dec 9, 2025·0 cites·6 claims
- 3874US11479614B2Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptorsAUTOLUS LTD·Filed 2020·Granted Oct 25, 2022·0 cites·27 claims
- 3974US2020181232A1CellAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 4074US2024309400A1VectorsAUTOLUS LTD·Filed 2023·Application pending·0 cites
- 4174US2021187026A1CellAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 4274US2021154229A1CellAUTOLUS LTD·Filed 2020·Application pending·0 cites
- 4373US2024307440A1Cell expressing a car and a transcription factor and its useAUTOLUS LTD·Filed 2023·Application pending·0 cites
- 4472US10604570B2Chimeric antigen receptor signalling system comprising heterodimerization domainsUCL BUSINESS PLC·Filed 2016·Granted Mar 31, 2020·1 cites·11 claims
- 4571US2020016204A1CellUCL BUSINESS PLC·Filed 2019·Application pending·0 cites
- 4670US11963981B2Chimeric antigen receptorAUTOLUS LTD·Filed 2019·Granted Apr 23, 2024·0 cites·16 claims
- 4769US2020016203A1CellUCL BUSINESS PLC·Filed 2019·Application pending·0 cites
- 4867US2019038672A1CellUCL BUSINESS PLC·Filed 2018·Application pending·0 cites
- 4966US2022275052A1ReceptorAUTOLUS LTD·Filed 2021·Application pending·0 cites
- 5066US2022267404A1CellAUTOLUS LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shaun Cordoba files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →